Lidocaine - Revision history

MDElliottMD: parser-claude: Lidocaine MedTemplate refill, Top 300 stub upgrade

2026-05-23T07:31:27Z

parser-claude: Lidocaine MedTemplate refill, Top 300 stub upgrade

← Older revision		Revision as of 07:31, 23 May 2026
Line 1:		Line 1:
	{{MedTemplate		{{MedTemplate
	\| generic = Lidocaine		\| generic = Lidocaine (hydrochloride)
	\| brand =		\| brand = Xylocaine (injectable, oral solution, topical), Lidoderm (patch), ZTLido (patch), Glydo (jelly), EMLA (with prilocaine, topical)
	\| structure =		\| structure =
	\| classes = Local anesthetic		\| classes = [[:Category:Local anesthetics\|Local anesthetic (amide class)]], [[:Category:Anesthetics\|Anesthetic]], [[:Category:Antiarrhythmics\|Antiarrhythmic (Vaughan Williams Class IB)]]
	\| ~~mechanism = Sodium channel blocker~~		\| uses = <vote slug="local-anesthesia-use">Local anesthesia for procedures and minor surgery (FDA; infiltration, nerve block, epidural, spinal)</vote>, <vote slug="ventricular-arrhythmias-use">Ventricular arrhythmias (FDA, IV)</vote>, <vote slug="postherpetic-neuralgia-use">Postherpetic neuralgia (FDA, Lidoderm 5% patch)</vote>, <vote slug="topical-pain-use">Topical analgesia for skin and mucosal pain (FDA)</vote>, <vote slug="pediatric-procedure-analgesia-use">Pediatric procedure analgesia (EMLA, LMX-4)</vote>
	\| uses =		\| starting_dose = Infiltration: 1-2% solution; '''4.5 mg/kg ceiling without epinephrine, 7 mg/kg with epinephrine'''. IV antiarrhythmic: 1-1.5 mg/kg bolus then infusion 1-4 mg/minute. Lidoderm patch: up to 3 patches per 12 hours
	\| starting_dose =		\| preparations = Injection 0.5-4% solutions (with and without epinephrine); topical cream 4-5%; transdermal patch 5% (Lidoderm), 1.8% (ZTLido); oral 2% viscous solution; jelly 2%; ophthalmic
	\| preparations =		\| fda_max = '''4.5 mg/kg (without epinephrine), 7 mg/kg (with epinephrine)''' for infiltration; serum level monitoring required for prolonged IV antiarrhythmic use
	\| fda_max =		\| pill_id =
	\| routes =		\| routes = Topical, infiltration, intravenous, regional anesthesia (spinal, epidural, nerve block), oral mucosal
	\| onset =		\| onset = <1 minute (IV); 1-2 minutes (infiltration); 30+ minutes (patch on adult skin, faster on thinner pediatric skin)
	\| duration =		\| duration = 30-90 minutes (infiltration without epinephrine); 90-200 minutes (with epinephrine); 12 hours (patch)
	\| halflife =		\| halflife = 1.5-2 hours<ref name="xylocaine-label">FDA Prescribing Information, Xylocaine (lidocaine hydrochloride), Hospira/Pfizer, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006488s092lbl.pdf</ref>
	~~\| bioavailability =~~		\| bioavailability = ~35% (oral, extensive first-pass; not used orally for systemic effect); ~100% (IV)<ref name="xylocaine-label" />
	~~\| pregnancy~~ =		\| pregnancy = Extensive use experience in obstetric anesthesia; broadly considered safe<ref name="xylocaine-label" />
	~~\| legal~~ =		\| legal = [[USLegal:Prescription only\|Rx-only]] for most formulations; some low-concentration topical formulations are [[USLegal:Over-the-counter\|OTC]] (4% cream)
	\| ~~intro =~~		\| mechanism = <vote slug="lidocaine-mech-claim">Amide-class local anesthetic. Reversible voltage-gated sodium channel blocker, preferentially binding the inactivated and open states, producing '''use-dependent block''' that is more effective on rapidly firing nerves (pain fibers) than slowly firing ones (motor fibers at low concentrations, sensory fibers preferentially). The Vaughan Williams Class IB antiarrhythmic mechanism applies the same sodium channel blockade to ventricular cardiac tissue at therapeutic plasma levels.</vote> Dose-limited by '''systemic toxicity''': CNS toxicity progresses through perioral numbness, tinnitus, seizures, and coma; cardiac toxicity through bradyarrhythmia and asystole at higher concentrations. Hepatic metabolism via CYP1A2 and CYP3A4; accumulates in hepatic impairment and heart failure<ref name="xylocaine-label" />.
	~~\| pharmacokinetics~~ =
	~~\| pharmacodynamics~~ =
	\| ~~indications~~ =
	~~\| dosing~~ =
	~~\| effects =~~
	~~\| interactions = <pharmaInteractions~~/>
	\| ~~pregnancy_details~~ =
	\| ~~monitoring =~~
	\| ~~counseling~~ =
	~~\| anecdotes~~ =
	~~\| seealso =~~
	~~\| references~~ =
	}}		}}

			== References ==
			<references />

	[[Category:Local ~~Anesthetics~~]]		[[Category:Local anesthetics]]
	[[Category:Anesthetics]]		[[Category:Anesthetics]]
			[[Category:Antiarrhythmics]]

MediaWiki default: Assign pharmacological categories from List_of_CNS-active_medicines

2026-05-14T15:07:06Z

Assign pharmacological categories from List_of_CNS-active_medicines

← Older revision		Revision as of 15:07, 14 May 2026
Line 31:		Line 31:
	}}		}}


			[[Category:Local Anesthetics]]
	[[Category:Anesthetics]]		[[Category:Anesthetics]]

MDElliottMD: Pharmacopedia: add

2026-05-14T03:30:56Z

Pharmacopedia: add <pharmaInteractions/>

← Older revision		Revision as of 03:30, 14 May 2026
Line 22:		Line 22:
	\| dosing =		\| dosing =
	\| effects =		\| effects =
	\| interactions =		\| interactions = <pharmaInteractions/>
	\| pregnancy_details =		\| pregnancy_details =
	\| monitoring =		\| monitoring =

MDElliottMD: Pharmacopedia: remove contraindications parameter

2026-05-14T02:40:38Z

Pharmacopedia: remove contraindications parameter

← Older revision		Revision as of 02:40, 14 May 2026
Line 22:		Line 22:
	\| dosing =		\| dosing =
	\| effects =		\| effects =
	~~\| contraindications =~~
	\| interactions =		\| interactions =
	\| pregnancy_details =		\| pregnancy_details =

MDElliottMD: Added empty fda_max parameter to MedTemplate call

2026-05-13T02:32:55Z

Added empty fda_max parameter to MedTemplate call

← Older revision		Revision as of 02:32, 13 May 2026
Line 8:		Line 8:
	\| starting_dose =		\| starting_dose =
	\| preparations =		\| preparations =
			\| fda_max =
	\| routes =		\| routes =
	\| onset =		\| onset =
Line 32:		Line 33:

	[[Category:Anesthetics]]		[[Category:Anesthetics]]

MDElliottMD: Expand stub to full MedTemplate parameter set

2026-05-13T01:00:00Z

Expand stub to full MedTemplate parameter set

@@ Line 1: / Line 1: @@
 {{MedTemplate
-| generic           = Lidocaine
+| generic            = Lidocaine
-| classes           = Local anesthetic
+| brand              =
-| mechanism         = Sodium channel blocker
+| structure          =
 }}
 [[Category:Anesthetics]]

MDElliottMD: Auto-created stub

2026-05-13T00:00:00Z

Auto-created stub

New page

{{MedTemplate
| generic = Lidocaine
| classes = Local anesthetic
| mechanism = Sodium channel blocker
}}
[[Category:Anesthetics]]